Phastar, global specialist biometrics contract research organization (CRO), has been named as a finalist for the Best Contract Research Organization – Specialist Providers category at the 2024 Scrip Awards. Phastar was recognized for its Clinical Intelligence Portal, a high-quality data analytics, visualization, and advanced Recruitment Forecasting app, as well as its continued commitment to lead the CRO industry in corporate responsibility. The Scrip Award winners will be announced during an award ceremony at Raffles London at the OWO on Wednesday 4th December.
The award category honors the role of CROs in drug development, particularly focusing on organizations that provide niche services. Entries were judged on the quality of the services provided to clients and the company’s achievements from 1st July 2023 to 30th June 2024. Phastar’s supporting evidence showcased its Clinical Intelligence Portal, launched in 2023. The portal leverages advanced data visualization and analytics techniques to transform data into actionable insights. A recent addition to the platform was the Recruitment Forecasting app which uses advanced statistical modeling to predict participant progression and treatment administration timelines, accounting for late site openings and real-time data updates.
Phastar also illustrated how they support their environment, social, and governance (ESG) goals.
- Phastar was certified as a B Corporation® in 2023 due to their ESG activities
- In October 2023, Phastar had its net-zero target approved by the Science Based Targets initiative (SBTi), including pledge to achieve the SBTi Net-Zero Standard by 2035
- Phastar continues their Phastar Cares scheme, pro-bono work that provides non-profit organizations with free access to statistical experts
- Phastar offers its staff paid volunteer days. These allow individuals the opportunity to contribute their time to causes close to their hearts
Graham Clark, CEO at Phastar, commented, “We are delighted to be shortlisted for the Best Contract Research Organization – Specialist Providers category at the 2024 Scrip Awards. This recognition underscores our expertise in delivering advanced clinical analytics, powered by therapeutic insights, deep domain knowledge, and cutting-edge AI and ML technologies to drive end-to-end clinical trial development. It also reflects our ongoing commitment to innovation in clinical analytics and our leadership in corporate responsibility across the CRO industry. “
